ArticlePharmaceuticals (Basel, Switzerland)2022

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma.

Jia-Hao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.